文献速递精神分裂症与精神病性障碍心境障碍

精神病性连续谱的遗传证据:多基因评分分析

Genetic evidence for the psychosis continuum: polygenic score analysis.
PubMed 文献 · Br J Psychiatry · 2026-10-14

该研究整合伦敦东南部5个队列共1315人(860例欧洲 ancestry、455例非洲 ancestry),按表型严重度分为对照、自报精神病性体验、未转化临床高危和首发精神病四组,比较精神分裂症、双相障碍和重性抑郁障碍多基因评分。欧洲 ancestry 中三种多基因评分均与表型严重度递增相关,精神分裂症多基因评分解释方差最大,多基因联合模型优于单变量模型;非洲 ancestry 中仅对照与首发精神病组差异显著。

要点

  • 欧洲 ancestry 中精神分裂症、双相障碍和重性抑郁障碍多基因评分均与精神病性连续谱表型严重度递增相关。
  • 精神分裂症多基因评分解释方差最大,且未转化临床高危组介于对照与首发精神病之间。
  • 三种多基因评分联合模型解释方差优于任一单变量模型,支持跨诊断遗传易感性。

核心结论

  • 研究提供生物学证据支持精神病性连续谱框架,欧洲 ancestry 中精神分裂症多基因评分差异提示未转化临床高危个体具有中间遗传易感性。
  • 多基因联合模型解释额外方差,支持跨诊断遗传易感性。
  • 非洲 ancestry 中多基因评分预测效力仍待提高。

研究设计与样本

  • 研究整合5个伦敦东南部队列,共N=1315(860例欧洲 ancestry、455例非洲 ancestry),按表型严重度分为4个有序组。
  • 4组分别为对照(n=647)、自报精神病性体验(n=89)、未转化临床高危(n=124)和首发精神病(n=455)。
  • 计算 ancestry 特异性精神分裂症、双相障碍和重性抑郁障碍多基因评分,采用有序逻辑回归比较组间差异。

主要发现

  • 欧洲 ancestry 中,精神分裂症多基因评分升高与表型严重度增加相关(OR 1.72,p=4.57×10^-15)。
  • 欧洲 ancestry 中,双相障碍多基因评分(OR 1.56,p=1.03×10^-10)和重性抑郁障碍多基因评分(OR 1.44,p=4.86×10^-8)亦与表型严重度增加相关。
  • 欧洲 ancestry 中,精神分裂症多基因评分解释方差最大(R²=0.084),临床高危与对照间(β=0.32,p=0.027)、首发精神病与临床高危间(β=0.38,p=0.017)存在显著差异。
  • 欧洲 ancestry 中,三种多基因评分联合模型解释方差(R²=0.105)优于单变量模型。
  • 非洲 ancestry 中,精神分裂症多基因评分呈类似趋势,但仅对照与首发精神病组差异显著(β=0.27,p=0.037)。

关键数值与推荐

  • 欧洲 ancestry 中精神分裂症多基因评分与表型严重度的 OR 为1.72(p=4.57×10^-15)。
  • 欧洲 ancestry 中双相障碍多基因评分 OR 为1.56(p=1.03×10^-10),重性抑郁障碍多基因评分 OR 为1.44(p=4.86×10^-8)。
  • 欧洲 ancestry 中精神分裂症多基因评分解释方差 R²=0.084,联合模型 R²=0.105。
  • 非洲 ancestry 中仅对照与首发精神病组精神分裂症多基因评分差异显著(β=0.27,p=0.037)。

临床怎么用

  • 多基因评分目前不适用于个体临床预测,但支持将精神病性体验至首发精神病视为连续谱进行跨诊断评估。
  • 临床高危未转化个体可能具有中间遗传负荷,提示需要动态随访而非仅按是否转化二分。
  • 跨诊断遗传易感性提示临床评估应关注心境与精神病性症状的共病与连续变化。

局限性

  • 非洲 ancestry 样本中多基因评分预测效力有限,限制了跨 ancestry 推广。
  • 研究为观察性队列设计,不能推断因果。
  • 多基因评分解释方差较小,临床个体化应用价值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The psychosis continuum conceptualises psychotic phenomena as existing on a spectrum from subclinical experiences to psychotic disorders. Despite epidemiological and clinical evidence in support of this model, few studies have examined polygenic liability across the severity continuum: from subclinical experiences to first-episode psychosis (FEP). AIMS: To map polygenic liability for schizophrenia (SCZ), bipolar disorder and major depressive disorder (MDD) across the psychosis continuum. We hypothesised that schizophrenia polygenic scores (SCZ-PGS) would track phenotypic severity most closely across this continuum. METHOD: We harmonised data from 5 south-east London cohorts (N = 1315; 860 European, 455 African ancestries) across 4 ordered groups indicative of different levels of phenotypic severity: controls (n = 647), individuals with self-reported psychotic experiences (n = 89), individuals at clinical high risk (CHR) that did not convert to psychosis (n = 124) and individuals with FEP (n = 455). We computed ancestry-specific PGS for SCZ, bipolar disorder and MDD and compared these across groups using ordinal logistic regression. RESULTS: In European ancestry participants, elevated SCZ-PGS (odds ratio 1.72, p = 4.57 × 10-15), bipolar disorder-PGS (odds ratio 1.56, p = 1.03 × 10-10) and MDD-PGS (odds ratio 1.44, p = 4.86 × 10-8) were individually associated with increasing phenotypic severity. SCZ-PGS explained the largest variance (R2 = 0.084) across the psychosis continuum and showed pairwise differences between CHR and controls (β = 0.32, p = 0.027), and between FEP and CHR (β = 0.38, p = 0.017). Multivariable models, combining three PGS, outperformed univariable models (R2 = 0.105). Similar trends in SCZ-PGS across the psychosis continuum phenotype were seen in African ancestry participants, but only controls and FEP groups differed significantly (β = 0.27, p = 0.037). CONCLUSIONS: Our findings provide biological evidence supporting the psychosis continuum framework. In European ancestry, SCZ-PGS differences suggest that CHR who do not transition to psychosis have intermediate genetic vulnerability. Multivariable models, utilising all three PGS, explained additional variance compared with univariable ones, supporting transdiagnostic genetic liability. Improving PGS predictive power in African ancestry remains a priority.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Haussler SM, Prata D, Kempton MJ, et al. Genetic evidence for the psychosis continuum: polygenic score analysis. Br J Psychiatry. 2026. PMID: 42872493. doi:10.1192/bjp.2026.10795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。